Mode
Text Size
Log in / Sign up

Digital health tools may ease anxiety and depression in colorectal cancer patientsDigital health tools may ease anxiety and depression in colorectal cancer patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Digital health interventions may reduce anxiety and depression in colorectal cancer patients, but evidence is low-certainty.

A recent meta-analysis evaluated digital health interventions for colorectal cancer patients, focusing on anxiety, depression, and quality of life. The study pooled data from 2018 CRC patients, comparing digital interventions to control conditions. Results indicated potential reductions in anxiety (SMD = -0.90, 95% CI: -1.59 to -0.22) and depression (SMD = -0.93, 95% CI: -1.64 to -0.21), alongside improvements in quality of life (SMD = 0.78, 95% CI: 0.19 to 1.36).

However, the evidence was marked by substantial heterogeneity and low certainty, limiting definitive conclusions. Safety data were not reported, and no adverse events or discontinuations were noted. The findings suggest digital health tools hold promise for supportive care in this population, but they should be interpreted cautiously.

Practice relevance highlights that these interventions could reduce anxiety and depression while enhancing quality of life among CRC patients. Yet, high-quality randomized controlled trials are required to establish more definitive conclusions, as the current evidence is not robust enough for widespread clinical adoption.

A meta-analysis of 2,018 colorectal cancer patients examined whether digital health interventions, such as apps or online programs, could affect anxiety, depression, and quality of life compared to control conditions. The study combined results from multiple earlier trials to look for overall patterns.

The analysis found that digital health interventions were associated with potential reductions in anxiety and depression, and an improvement in quality of life. The effect sizes were moderate to large, but the certainty of the evidence was rated as low due to substantial heterogeneity among the studies.

No safety concerns were reported in the included studies, but the authors noted that the evidence is not definitive. The main reason to be cautious is the low certainty and variability between studies, meaning the true effect could be different.

Realistically, this suggests digital health tools hold promise for supporting mental health and well-being in colorectal cancer patients, but high-quality randomized trials are needed to confirm these findings before they can guide care.

What this means for you:
Digital tools may help colorectal cancer patients with anxiety and depression, but more robust trials are needed.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundColorectal cancer (CRC) patients generally experience distressing psychological symptoms, including anxiety and depression, which significantly diminish their quality of life. Digital health interventions have emerged as a promising complementary approach to managing these challenges. This meta-analysis of randomized controlled trials aimed to determine the effects of digital health interventions on anxiety, depression, and quality of life in CRC patients.MethodsA comprehensive literature search was conducted across ten databases (PubMed, Web of Science, Scopus, Embase, Cochrane Library, CINAHL, CNKI, VIP, WanFang, and CBM) from inception to February 28, 2026. Randomized controlled trials evaluating the effects of digital health interventions on anxiety, depression, and quality of life among CRC patients were eligible for inclusion. The Cochrane Risk of Bias tool 2.0 (ROB 2.0) was employed to assess methodological quality, and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework was applied to grade the certainty of evidence for each outcome. A random-effects model was used for all quantitative syntheses.ResultsA total of 15 randomized controlled trials comprising 2018 CRC patients were included. Pooled analyses revealed that digital health interventions were associated with a potential reduction in anxiety (SMD = -0.90, 95% CI: -1.59 to -0.22, I² = 93%, low certainty evidence) and depression (SMD = -0.93, 95% CI: -1.64 to -0.21, I² = 94%, low certainty evidence), and improvement in quality of life (SMD = 0.78, 95% CI: 0.19 to 1.36, I² = 96%, low certainty evidence) compared to control conditions.ConclusionsOur findings revealed that digital health interventions hold promise in reducing anxiety and depression and enhancing quality of life among CRC patients. Given the limitations posed by substantial heterogeneity and low evidence certainty, high-quality randomized controlled trials are required to establish more definitive conclusions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.